This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

GRANULOCYTOPENIA FOLLOWING NEOARSPHENAMINE THERAPY IN A PATIENT WHO SUBSEQUENTLY RECEIVED MAPHARSEN WITHOUT UNTOWARD REACTION

NORMAN N. EPSTEIN, M.D.; ERNEST H. FALCONER, M.D.

Arch Derm Syphilol. 1940;42(5):909-918.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Blood dyscrasias following administration of the arsphenamines have always been regarded with considerable concern. The development of such a reaction to arsphenamine therapy is an absolute contraindication to its further use, as well as to use of other members of the arshpenamine group.

McCarthy and Wilson,¹ in an excellent discussion of this subject, divided these dyscrasias into three groups: namely, thrombopenic purpura, granulocytopenia and aplastic anemia. While the majority of these reactions conform to one of these classifications, there are occasional reactions to these drugs which affect the blood and do not fall into any of these classes.

The purposes of this paper are:

1. To compare briefly the effects of neoarsphenamine and mapharsen on the formed elements of the blood of patients undergoing treatment for syphilis. The complete data on these investigations will be published in a separate report.
   
2. To report in detail a case of granulocytopenia
   

Author Affiliations
SAN FRANCISCO

From the Department of Dermatology and the Division of Medicine of the University of California Medical School.

Footnotes
Read at the Sixty-Third Annual Meeting of the American Dermatological Association, Inc., Colorado Springs, Colo., June 1, 1940.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?